39.84 1.45 (3.78%)

29.95% Fall from 52W High

795.8K XNAS Volume

XNAS 27 Mar, 2025 5:30 PM (EDT)

Detailed Stock Analysis for MoonLake Immunotherapeutics - Ordinary Shares - Class A with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in